肝移植后肝炎相关再生障碍性贫血患儿行造血干细胞移植的优异结局
本研究报道了10例因肝炎相关再生障碍性贫血在肝移植后接受以替代供者为主的造血干细胞移植的极高危患儿经验。中位随访肝移植后38个月,总生存率为90%,存活患儿血象、肝功能及体能状态均正常,未发生肝脏相关并发症或显著移植物抗宿主病。及时的前置造血干细胞移植联合多学科支持可挽救生命。
要点
- 肝移植后肝炎相关再生障碍性贫血患儿行替代供者造血干细胞移植总生存率达90%。
- 存活患儿血象、肝功能及体能状态均正常,无肝脏相关并发症或显著GVHD。
- 移植后感染及非感染并发症经多学科支持成功处理,及时前置移植可救命。
核心结论
- 肝移植后肝炎相关再生障碍性贫血患儿接受以替代供者为主的造血干细胞移植可获得90%总生存率。
- 及时的前置造血干细胞移植联合肝移植与移植团队紧密协作及多学科支持可挽救生命。
研究设计与样本
- 单中心经验报道,纳入10例肝移植后发生肝炎相关再生障碍性贫血的儿童。
- 造血干细胞移植以替代供者为主,中位随访时间为肝移植后38个月。
主要发现
- 总生存率为90%,中位随访肝移植后38个月。
- 存活患儿血象正常、肝功能正常、体能状态正常。
- 未发生肝脏相关并发症或显著移植物抗宿主病。
- 移植后多种感染及非感染并发症经多学科支持成功治疗。
临床怎么用
- 对肝移植后肝炎相关再生障碍性贫血患儿,可考虑及时行前置造血干细胞移植,即使使用替代供者。
- 肝移植团队与造血干细胞移植团队需紧密协作,并提供适当的多学科支持。
局限性
- 样本量仅10例,属于单中心经验报道。
- 以替代供者为主,未设对照组,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatitis-associated aplastic anaemia is a rare entity that can sometimes be life-threatening due to its rapid progression to liver failure, necessitating an urgent liver transplantation (LT). Treating severe aplastic anaemia following an LT can be very challenging. While immunosuppressive therapy (IST) has been reported to have some success, the vulnerable state of these patients in addition to the time taken for IST to work makes this a less suitable option for the majority of patients. Haematopoietic stem cell transplantation (HSCT) with matched related donors has been reported as a curative option; there has been less success using alternate donors. Here, we present our experience of predominantly alternate donor HSCT following liver transplantation in an extremely high-risk group of 10 children. Overall survival was 90% at a median of 38 months post-LT. Surviving children have normal blood counts, normal liver function and performance status. No liver-related complications or significant graft versus host disease were encountered. Multiple infective and non-infective post-HSCT complications were successfully treated with excellent multidisciplinary input. Upfront HSCT, even with alternate donors, can be lifesaving if performed in a timely manner, following close liaison between liver transplantation and HSCT teams and with the appropriate multidisciplinary support.
引用
- Meena SK, Kancharla A, Mohamed AI, et al. Excellent outcomes in children after haematopoietic stem cell transplantation for hepatitis-associated aplastic anaemia following liver transplantation. Br J Haematol. 2026. PMID: 41527175. doi:10.1111/bjh.70328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。